Molecular Profile and Matched Targeted Therapy for Advanced Breast Cancer Patients
(1) Background: Precision oncology is opening new treatment opportunities for patients suffering from solid tumors. In the last two decades, the advent of CDK4/6 inhibitors, immunotherapy, and antibody–drug conjugates (ADC) improved survival outcomes for advanced or metastatic breast cancers (BC). N...
Gardado en:
| Principais autores: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
MDPI AG
2023-02-01
|
| Series: | Current Oncology |
| Assuntos: | |
| Acceso en liña: | https://www.mdpi.com/1718-7729/30/2/191 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|
